Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease
{{output}}
Metabolic Dysfunction-Associated Steatotic Liver Disease(MASLD) is increasing in prevalence worldwide and has become the greatest potential risk for cirrhosis and hepatocellular liver cancer. Currently, the role of gut microbiota in the development of MASLD ha... ...
